Altamira Therapeutics (CYTOF) Q1 2026 Earnings

Mar 31Confirmed
Q3 2024
Q2 2025
Q3 2025
Q1 2026
-2.38
-1.77
-1.15
-0.54

Details

Expected EPS
-0.647709979
Actual EPS
N/A
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Altamira Therapeutics⁩ (⁦CYTOF⁩) will report earnings of for ⁦Q1 2026⁩ on March 31, 2026.

0 Comments

Share your thoughts